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ABSTRACT To combat the high burden of rotavirus gastroenteritis, multiple African
countries have introduced rotavirus vaccines into their childhood immunization pro-
grams. Malawi incorporated a G1P[8] rotavirus vaccine (Rotarix) into its immunization
schedule in 2012. Utilizing a surveillance platform of hospitalized rotavirus gastroen-
teritis cases, we examined the phylodynamics of G1P[8] rotavirus strains that circu-
lated in Malawi before (1998 to 2012) and after (2013 to 2014) vaccine introduction.
Analysis of whole genomes obtained through next-generation sequencing revealed
that all randomly selected prevaccine G1P[8] strains sequenced (n  32) possessed a
Wa-like genetic constellation, whereas postvaccine G1P[8] strains (n  18) had a DS-
1-like constellation. Phylodynamic analyses indicated that postvaccine G1P[8] strains
emerged through reassortment events between human Wa- and DS-1-like rotavi-
ruses that circulated in Malawi from the 1990s and hence were classiﬁed as atypical
DS-1-like reassortants. The time to the most recent common ancestor for G1P[8]
strains was from 1981 to 1994; their evolutionary rates ranged from 9.7  104 to
4.1  103 nucleotide substitutions/site/year. Three distinct G1P[8] lineages chrono-
logically replaced each other between 1998 and 2014. Genetic drift was the likely
driver for lineage turnover in 2005, whereas replacement in 2013 was due to reas-
sortment. Amino acid substitution within the outer glycoprotein VP7 of G1P[8]
strains had no impact on the structural conformation of the antigenic regions, sug-
gesting that it is unlikely that they would affect recognition by vaccine-induced neu-
tralizing antibodies. While the emergence of DS-1-like G1P[8] rotavirus reassortants
in Malawi was therefore likely due to natural genotype variation, vaccine effective-
ness against such strains needs careful evaluation.
IMPORTANCE The error-prone RNA-dependent RNA polymerase and the segmented
RNA genome predispose rotaviruses to genetic mutation and genome reassortment,
respectively. These evolutionary mechanisms generate novel strains and have the
potential to lead to the emergence of vaccine escape mutants. While multiple Afri-
can countries have introduced a rotavirus vaccine, there are few data describing the
evolution of rotaviruses that circulated before and after vaccine introduction. We re-
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port the emergence of atypical DS-1-like G1P[8] strains during the postvaccine era in
Malawi. Three distinct G1P[8] lineages circulated chronologically from 1998 to 2014;
mutation and reassortment drove lineage turnover in 2005 and 2013, respectively.
Amino acid substitutions within the outer capsid VP7 glycoprotein did not affect the
structural conformation of mapped antigenic sites, suggesting a limited effect on
the recognition of G1-speciﬁc vaccine-derived antibodies. The genes that constitute
the remaining genetic backbone may play important roles in immune evasion, and
vaccine effectiveness against such atypical strains needs careful evaluation.
KEYWORDS rotavirus, phylodynamics, genome reassortment, lineage turnover,
whole-genome sequencing, Malawi
Diarrhea is a leading cause of mortality in children under the age of 5 years globally(1, 2). The majority of hospitalizations and deaths of infants due to severe
dehydrating diarrhea are caused by group A rotaviruses (RVAs) (3). The World Health
Organization (WHO) recommended the universal introduction of rotavirus vaccines in
2009, particularly in countries where the diarrhea mortality rate is high (4). A global
decline from 528,000 to 215,000 rotavirus-associated deaths per year among children
5 years of age between 2000 and 2013 has been reported, and live-attenuated oral
rotavirus vaccines (Rotarix [RV1] and RotaTeq [RV5]) have now been incorporated into
the national immunization programs of over 60 countries worldwide (5).
RVAs are members of the Reoviridae virus family. They are enveloped icosahedric
viruses that contain a triple-layered capsid encasing 11 genome segments of
double-stranded RNA (dsRNA). The rotavirus genome encodes six structural pro-
teins (VP1 to VP4, VP6, and VP7) and ﬁve to six nonstructural proteins (NSP1 to
NSP5/NSP6) (6). Nucleotide homology cutoff values for the open reading frame
(ORF) for each genome segment are used to classify rotavirus strains on the basis
of the whole-genome composition (7, 8). To date, 35 G (VP7), 50 P (VP4), 26 I (VP6),
21 R (VP1), 19 C (VP2), 19 M (VP3), 30 A (NSP1), 20 N (NSP2), 21 T (NSP3), 26 E (NSP4),
and 21 H (NSP5) genotypes have been described (8–12). (http://rega.kuleuven.be/
cev/viralmetagenomics/virus-classiﬁcation).
Genotypes G1 to G4, G9, and G12 in association with genotype P[4], P[6], or P[8] are
the predominant genotypes associated with human rotavirus infection worldwide (6,
13–15). Although several G and P genotype combinations have been detected among
human rotaviruses, the genotypes for the other nine genes are limited to predomi-
nantly genotype 1 (I1-R1-C1-M1-A1-N1-T1-E1-H1; Wa-like) and genotype 2 (I2-R2-C2-
M2-A2-N2-T2-E2-H2; DS-1-like) (16). For instance, typically, G1P[8], G3P[8], G4P[8],
G9P[8], and G12P[8] RVAs have a Wa-like genotype constellation, whereas G2P[4] and
G8P[4] or G8P[6] strains usually possess a DS-1-like constellation (16–18). The seg-
mented RNA genome of rotaviruses and their error-prone RNA-dependent RNA poly-
merase, which lacks proofreading activity (6), allow various evolutionary mechanisms,
including genetic mutation, recombination, and reassortment. This leads to the emer-
gence of distinct lineages within individual genotypes or reassortant viruses containing
segments from different progenitor strains (6, 19, 20).
Novel double-reassortant DS-1-like G1P[8] rotaviruses have recently emerged in
Southeast Asia. These atypical G1 strains were initially detected in outbreaks of gas-
troenteritis among Japanese children (21–23), followed by reports from Thailand (24,
25) and then Vietnam (26). To date, there is no evidence that these atypical G1 strains
are widespread. Rotavirus strain surveillance conducted in Blantyre, Malawi, since 1997,
and the introduction of the monovalent, Wa-like G1P[8] rotavirus vaccine (Rotarix or
RV1) into Malawi’s childhood immunization program in 2012 allow the study of the
evolution of G1P[8] strains before and after vaccine introduction. We have, for the ﬁrst
time, detected DS-1-like G1P[8] rotavirus strains in Africa, which became predominant
following vaccine introduction. The evolutionary forces that were associated with the
emergence of the atypical G1P[8] rotavirus strains were also determined.
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RESULTS
Emergence of reassortant DS-1-like G1P[8] rotavirus strains. All prevaccine (33.4%;
1,634/4,888) and postvaccine (22.6%; 477/2,109) rotavirus-positive stool samples col-
lected from children presenting with acute severe diarrhea at Queen Elizabeth Central
Hospital (QECH) in Blantyre, Malawi, were genotyped as part of ongoing rotavirus
surveillance (27–30). Multiple strains were characterized, and G1P[8] rotaviruses were
consistently predominant strains that were detected each year before (39.4%; 554/
1406) and after (31.4%; 95/303) vaccine introduction (Fig. 1a; see also Fig. S1 in the
supplemental material). Whole-genome sequences of 32 prevaccine G1P[8] strains
(collected between 1998 and 2012) and 18 postvaccine G1P[8] strains (collected from
2013 to 2014) were successfully generated (see Table S1 in the supplemental material
for the yearly distribution). Interruption of surveillance in 2010 meant that no G1P[8]
strains were available between 2010 and 2011. Among the prevaccine G1P[8] strains, 31
FIG 1 Rotavirus strains, genetic constellations, and phylogenetic networks of G1P[8] rotaviruses detected in Malawian children at QECH from 1997 to 2015. (a)
Schematic representation of the proportions of all genotypes detected in rotavirus-positive stool samples. The size of the circle is directly proportional to the
frequency of detection of G and P genotypes. There were no rotavirus surveillance activities in 2010; hence, samples were not collected at this time. (b) Bayesian
maximum clade credibility tree for concatenated whole-rotavirus-genome sequences illustrating the genetic constellation and reassortment patterns for 32 pre-
and 18 postvaccine G1P[8] strains from Malawi as well as the prototype Wa and DS-1 strains for comparison. Genotype and genogroup assignments for each
segment were based on nucleotide sequence identities, assigned by using RotaC. Genome segments that were assigned the same genotype are shown with
the same color and genotype numbers. (C) Phylogenetic network of complete concatenated whole-genome sequences of G1P[8] rotavirus strains detected in
Malawi from 1998 to 2014. Branches are drawn to scale, and splits in the network indicate reassortments. Network clusters are color-coded and named in
accordance with their phylogenic lineages (L1 to L3) that correlated with the time of strain isolation before or after rotavirus vaccine introduction. Clusters L1
(green) and L2 (blue) contain prevaccine G1P[8] strains, whereas L3 (red) contains postvaccine strains. Network subclusters within each main cluster are shaded
in blue (L1), red (L2), or orange (L3).
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had the G1-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1 genotype constellation and hence were
designated Wa-like G1P[8] strains, whereas 1 had the G1-P[8]-I1-R1-C1-M1-A1-N1-T2-
E1-H1 genotype constellation and hence was designated a monoreassortant Wa-like
G1P[8] strain. In contrast, 16/18 of the postvaccine G1P[8] strains had a DS-1-like
genotype constellation (G1-P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2) and hence were desig-
nated atypical double-reassortant DS-1-like G1P[8] strains. The remaining two postvac-
cine G1P[8] strains (BID1LN and BID230) had Wa-like VP1 (R1) and Wa-like NSP3 (T1)
genes, respectively, and hence were designated atypical triple-reassortant DS-1-like
G1P[8] strains (Fig. 1b and Table S1).
Atypical postvaccine G1P[8] strains emerged through genome reassortment
between Wa-like and DS-1-like human rotaviruses. While the concatenated se-
quences of all 11 genome segments of pre- and postvaccine G1P[8] rotaviruses clustered
with prototype Wa- and DS-1-like strains, respectively (Fig. 1b), phylogenetic networks
constructed by using characterized concatenated whole-genome sequences of G1P[8]
strains revealed frequent reassortment events between strains from the same or different
network clusters (Fig. 1c). The Malawi G1P[8] strains were distributed into three main
phylogenetic network clusters (L1, L2, and L3), which also contained multiple subclusters
(shaded within main clusters in Fig. 1c). The L1 phylogenetic cluster contained strains that
circulated from 1998 to 2004, and strains detected from 2005 to 2012 were grouped into
the L2 cluster, while the L3 cluster consisted only of postvaccine G1P[8] strains that
circulated from 2013 to at least 2014 in Blantyre.
The phylogenetic relationship of Malawi G1P[8] strains was inferred by using the
maximum likelihood method, for which complete nucleotide sequences of RVAs avail-
able in GenBank and sequences of Wa-like (VP4 and VP7 only) and DS-1-like (the other
nine genes) strains from Malawi were used. The DS-1-like genes of the postvaccine
G1P[8] reassortants clustered closely with those of G2 strains that circulated simulta-
neously in Malawi (see Fig. S2 in the supplemental material) and not with DS-1-like
G1P[8] strains identiﬁed in Southeast Asia and Japan. Sequences within each cluster
were 95 to 99.8% similar (calculated by using nucleotide identity matrices [data not
shown]).
All 11 genome segments of the G1P[8] strains were undergoing purifying selection,
thus potentially resulting in stabilizing selection following the purging of deleterious
variants arising during error-prone rotavirus replication due to its RNA genome (Table
1). The genetic algorithm for recombination detection (GARD) (31) and single-
breakpoint recombination (SBP) (32) did not identify any recombination events within
each genome segment of the study strains (Table 1). Thus, the changes in the genetic
constellation of postvaccine G1P[8] strains were likely generated through the exchange
of a whole gene segment (reassortment) between circulating Wa-like and DS-1-like
human rotaviruses.
TABLE 1 Evolutionary selective forces and recombination in all 11 proteins of the
Malawian G1P[8] rotavirus strainsa
Protein dN/dS by SLAC  (/) by FUBAR
VP1 0.0502 2.22
VP2 0.0538 2.67
VP3 0.0965 2.47
VP4 0.1052 3.15
VP6 0.0310 4.66
VP7 0.2033 6.01
NSP1 0.2239 4.21
NSP2 0.0920 5.62
NSP3 0.0870 5.44
NSP4 0.1097 7.10
NSP5 0.1097 7.47
aShown are posterior distributions of synonymous () and nonsynonymous () substitution rates over sites
as well as mean posterior probabilities for a  (/) value of 1 at a site. The consensus selective force in
all cases was purifying selection, and there was no recombination determined by GARD or SBP.
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G1P[8] strains that circulated in Malawi between 1998 and 2014 exhibit dis-
tinct replacement dynamic patterns. Bayesian inferences of time-measured trees
were individually constructed for each of the 11 genome segments of the G1P[8] strains
to further determine their evolutionary dynamics. As illustrated by phylogenetic net-
works, prior to the emergence of the reassortant L3 lineage, both structural and
nonstructural genes segregated into at least 2 distinct lineages with a common
ancestor in the mid-1990s or before (Fig. 2; see also Fig. S3 in the supplemental
material). For NSP1, NSP2, NSP3, VP1, VP2, VP3, and VP6, a single lineage (L1) was
predominant until the mid-2000s (2003 to 2005), and following its disappearance,
strains forming a second lineage, L2, circulated until the emergence of the DS-1-like
G1P[8] reassortant strains. For the VP4, VP7, and NSP4 genes, two clusters cocirculated
until 2004, and replacement with strains in L2 did not occur until later, between 2010
and 2012. In 2013, VP7- and VP4-encoding genes of the emergent reassortant strains
also formed a third cluster with a likely common ancestor with strains in L2. Both
maximum clade credibility (MCC) coalescent framework and maximum likelihood
phylogenetic approaches showed that G1P[8] strains acquired DS-1-like genome seg-
ments (genotype 2) in the nine non-VP4 and non-VP7 genes in 2013, outcompeting
typical Wa-like L2 variants (genotype 1) during the postvaccine era (Fig. 2 and Fig. S2
to S4). These analyses also showed that the post-2013 Malawi DS-1-like G1P[8] reas-
sortant strains clustered with or were derived from Wa-like G1P[8] strains and DS-1-like
G2 strains that cocirculated in Malawi and hence emerged through reassortment
among local strains. The genes of Malawi DS-1-like G1P[8] strains clustered away from
those of DS-1-like reassortants that emerged recently in southeast Asian countries and
Japan, indicating that they were likely not imported.
FIG 2 Bayesian maximum clade credibility (MCC) time tree based on complete nucleotide sequences illustrating lineage
replacement within the genome segments encoding structural proteins of the G1P[8] strains that circulated in Malawi from
1998 to 2014. With the exception of VP4 and VP7 genes that had L2 and L3 genes sharing close ancestry, the rest had three
distinct G1P[8] lineages. L1, L2, and L3 represent lineages 1, 2, and 3, respectively.
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Since the postvaccine Malawi G1P[8] strains contained a DS-1-like genetic backbone,
only sequences for the Wa-like genome segments for G1P[8] strains generated in this
study were used for phylodynamic analysis of VP4 and VP7 genes, whereas cognate
genes of DS-1-like strains that were assigned various G and P types (Table S1), which
also circulated in Malawi from 1997 to 2014, were used to estimate evolutionary
dynamics for non-VP4 and non-VP7 genes for postvaccine G1P[8] strains (Fig. 3 and Fig.
S4). The calculated mean times per gene to the most recent common ancestor
(tMRCAs) ranged from the years 1986 to 1996 (Fig. 4a). When only non-VP4 and
non-VP7 genes (NSP1 to NSP4, VP1 to VP3, and VP6) for reassortant DS-1-like G1P[8]
and cognate genes of DS-1-like strains collected from Malawi between 1997 and 2014
were used to infer Bayesian time-measured trees, the tMRCA for the atypical G1P[8]
strains (L3 cluster) was estimated to range from 2009 to 2011, which was similar to
predominantly DS-1-like G2 strains that were detected after vaccine introduction (Fig.
3 and Fig. S4). Marginal differences between the mean evolutionary rates for each
genome segment were observed, which ranged from 9.7  104 to 4.1  103
nucleotide substitutions per site per year (Fig. 4b). VP2 had the lowest mutation rates
(9.7  104 nucleotide substitutions per site per year; 95% highest posterior density
[HPD] interval, 7.4  104 to 1.2  103 substitutions per site per year), whereas VP3
had the highest mutation rates (4.1  103 substitutions per site per year; HPD, 3.1 
103 to 5  103 substitutions per site per year) (Fig. 3 and 4b and Fig. S4).
We then utilized a Gaussian Markov random ﬁeld (GMRF) tree prior to investigate
whether Rotarix introduction had an impact on the relative population size of the
FIG 3 Bayesian MCC time tree based on complete nucleotide sequences of the structural proteins for G1P[8] strains from Malawi. Only DS-1-like genome
segments for typical DS-1-like strains that were assigned G2P[4], G2P[6], G8P[4], G8P[6], and G12P[6] outer capsid genotypes from Malawi were included to
calculate evolutionary dynamics for VP1- to VP4-, VP6-, and VP7-encoding genome segments for the atypical DS-1-like G1P[8] strains (L3 cluster).
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circulating G1P[8] strain. There was no evidence to suggest that vaccine introduction
affected either G1P[8] genetic diversity or population size for the VP4, VP7, NSP2, NSP3,
and NSP5 genes, as the peaks and troughs of their Skygrid plots exhibited similar stable
proﬁles just before (2005 to 2012) and after (2013 to 2014) vaccine use. In contrast,
genes encoding VP1 to VP3, VP6, and NSP1 had relatively stable proﬁles and also small
effective population sizes during the postvaccine era compared to those before vaccine
introduction, which could be natural, as similar downward trends were already occur-
ring before vaccine introduction (Fig. 4c).
Mutations within VP7 antigenic regions did not affect the structural confor-
mation of neutralizing epitopes essential for antigenic recognition by neutraliz-
ing antibodies.Mapped amino acid motifs that constitute neutralizing epitopes on the
outer capsid glycoprotein were compared between Rotarix and Malawian G1P[8]
strains. In total, 15 lineage-deﬁning amino acid substitutions were identiﬁed across the
entire VP7 sequence, with only 5 of these being located at mapped antigenic regions
7-1a (S123N and K291R) and 7-2 (AR C [M202T, M212T, and N221S]) (Fig. 5a). A single
amino acid substitution, N221S, located at one of these antigenic regions, differentiated
L3 from L2 cluster strains (Fig. 5).
FIG 4 Time to the most recent common ancestor (tMRCA), evolutionary rates for each genome segment of Malawian G1P[8] strains, and
comparative population dynamics of G1P[8] rotavirus strains circulating in Malawi, 1998 to 2014. (a) Evolutionary rates and tMRCAs for each
genome segment of the atypical Malawian G1P[8] strains shown together with their 95% highest posterior density (HPD) intervals. (b) Absolute
values for the means and ranges of evolutionary rates and tMRCA at 95% HPD intervals. (c) Phylogenies and relative genetic diversities estimated
by using the Gaussian Markov random ﬁeld (GMRF) model represent Bayesian Skygrid plots for VP1- to VP4-, VP6-, and NSP1- to NSP5-encoding
genome segments. Lines in the GMRF plot represent the mean relative genetic diversity through time.
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The VP7 structures of L1 to L3 strains and that of the Rotarix strain aligned perfectly
when superimposed (Fig. 5b), implying a conserved conformation consistent with the
conservation in chemical properties of the replacing amino acids. The replacing amino
acids did not appear to impact the structural conformation of the antigenic regions of
the glycocapsid protein of the G1P[8] strains circulating before and after vaccine
introduction (Fig. 5c to e).
DISCUSSION
Malawi was one of the ﬁrst African countries to introduce a rotavirus vaccine into its
infant immunization schedule in October 2012. By 2015, vaccine coverage had ex-
ceeded 95% (30). We enhanced rotavirus surveillance activities in the postvaccine
period in Malawi primarily to assess the impact of vaccine introduction on the burden
of rotavirus disease (27, 30). The availability of a collection of rotavirus strains isolated
before (1997 to 2012) (28) and after Rotarix introduction offered a rare opportunity to
assess the early impact of vaccine introduction on the genetic diversity of circulating
strains and their evolutionary patterns over time. In the present study, phylogenetic
analysis and evolutionary history were inferred for G1P[8] rotaviruses, the most prev-
alent rotavirus strains globally (6). In Malawi, G1P[8] strains were the only rotaviruses
consistently detected year to year, from 1998 to 2014, hence enabling a systematic
inference of evolutionary patterns over time. Furthermore, G1P[8] strains are homolo-
gous, with respect to VP7 and VP4 genotypes, to the Rotarix vaccine that is in use in
Malawi (33), hence permitting homologous genomic comparison.
While the prevaccine G1P[8] strains had a typical Wa-like genetic constellation (8, 16,
34, 35), the backbone of the G1P[8] strains detected after vaccine introduction pos-
FIG 5 Amino acid substitutions and structural conformation of the outer capsid glycoprotein of Malawian G1P[8] strains. (a) Complete VP7 sequences of
representative pre- and postvaccine G1P[8] strains aligned to that of RV1 exhibiting amino acid substitutions that occurred within the variable regions (VR) and
mapped antigenic regions (AR) over time. Lineage-deﬁning amino acid amino acid substitutions are highlighted in green, blue, and yellow for the L1,
L2, and L3 lineages, respectively. Pre- and postvaccine strains are shown with vertical green and red bars on the right, respectively. Strains belonging
to the L1, L2, and L3 phylogenetic clusters are shown with green, blue, and red bars, respectively, on the right. (b) Perfect alignment of superimposed VP7
structures exhibiting few differences between RV1 and L1 to L3 strains. Antigenic regions A, B, and C are shown in white. L1 to L3 and RV1 strains are shown
in yellow, green, blue, and red, respectively. (c to e) Surface visualization of VP7 from outside the virion on the 3-fold axis displaying amino acid differences
when structures for L1 (c), L2 (d), and L3 (e) G1P[8] strains were superimposed on the structure of the outer capsid glycoprotein of RV1. Numbers correspond
to the positions where mutations occurred.
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sessed a DS-1-like genotype constellation, which is associated most frequently with
G2P[4] strains, occasionally with G9 and G12 strains, and with G8P[4] or G8P[6] strains
in Africa (8, 17, 18, 36). The detection of atypical reassortant DS-1-like G1P[8] strains had
not been documented during 15 years of prevaccine rotavirus strain surveillance in
Malawi or elsewhere in Africa. Similar atypical reassortant DS-1-like G1P[8] strains
emerged recently in Southeast Asian countries where rotavirus vaccine use is limited
(21–26). Atypical DS-1-like G1P[8] strains from Malawi and Asia exhibited distinct
phylogenetic clustering patterns in all 11 genome segments, indicating that these
atypical DS-1-like G1P[8] strains most likely emerged independently in Malawi and Asia
and did not arise through importation. In addition, (i) tight clustering between the G
and P genes of the atypical Malawian G1P[8] strains with those of other G1P[8] Wa-like
strains, (ii) monophyletic clustering between non-G and non-P genes of atypical
Malawian G1P[8] strains and those of other Malawian DS-1-like strains, and (iii) evidence
of frequent reassortment events among DS-1- and Wa-like strains circulating in Malawi
during the study period as revealed by phylogenetic networks suggest that the atypical
Malawian G1P[8] strains emerged locally through genome reassortment among cocir-
culating Wa- and DS-1-like strains. This is further supported by the detection of a high
prevalence of G2 strains in Malawi from 2012 (27, 30), thus providing the required
circulating strains to allow the emergence of Wa/DS-1-like reassortant strains.
The Malawian G1 mutation rate falls in the same range as those of rotavirus G9 and
G12 strains (37–41). Zeller et al. (35) recently analyzed the phylodynamics of typical
Wa-like G1P[8] strains that circulated before and after vaccine introduction in Belgium
and Australia. Unlike the Malawian G1P[8] strains, all G1P[8] strains from Belgium and
Australia had a Wa-like genetic constellation, and their tMRCA ranged from 1846 to
1945, whereas their evolutionary rates, which ranged from 6.05  104 to 1.01  103
nucleotide substitutions per site per year, were similar to those for Malawian G1P[8]
strains. These rates are relatively lower than the known rates of RNA viruses (42),
possibly due to the double-stranded nature of the rotavirus genome.
The emergence of the atypical reassortant DS-1-like G1P[8] strains in Malawi coin-
cided with the programmatic rollout of Rotarix. Our data suggest that the atypical
Malawian DS-1-like G1P[8] strains were derived from a combination of reassortment
and drift of rotaviruses that were circulating locally since the 1990s. We found that at
least three G1P[8] lineages were circulating in Malawi from 1998 to 2014. The diversity
of the circulating G1P[8] variants exhibited periodic lineage replacements, similarly to
inﬂuenza virus (43), dengue virus (44), and other enteric viruses such as noroviruses
(45), where lineage replacement also appears to be an important evolutionary mech-
anism in response to herd immunity (35, 46, 47). Lineage diversity and replacement
coincided temporally for blocks of genes and can be explained by drift and reassort-
ment events occurring hand in hand.
Although the detection of DS-1-like G1P[8] strains coincided with the widespread
use of a G1P[8] Rotarix rotavirus vaccine in Malawi in 2013, it is difﬁcult to ascertain the
role that the vaccine had in the emergence of these atypical strains considering the
short postvaccine period. The data from phylodynamic analyses suggested that these
strains were derived from those strains circulating in the human population well before
vaccine introduction. It was difﬁcult to determine the effect of vaccine introduction on
the effective population size of the circulating G1P[8] strains, as only postvaccine G1
strains from 2013 and 2014 were analyzed, a time which was too early to detect genetic
variations in the virus population size. The frequent detection of DS-1-like G2 strains
just before Rotarix introduction and during the postvaccine era in Malawi (27, 30) may
indicate a natural surge of DS-1-like rotaviruses during this period, similarly to G2 cyclic
seasonal epidemic patterns that have been observed in many countries, including
Africa (48, 49). However, the predominance of reassortant DS-1-like G1P[8] strains after
vaccine introduction could suggest that there is positive selection for atypical G1P[8]
strains and that such selection may not be driven exclusively by the VP7 and VP4
speciﬁcities. The DS-1-like genotype constellation was, however, found in rotavirus
diarrhea cases regardless of the vaccination status of the children (48% were vaccinated
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[data not shown]). The relatively fewer rotavirus G1P[8] genomes that were analyzed
are a potential limitation of the present study; as such, sequencing of additional G1P[8]
strains that circulated in Malawi post-2014 is under way to determine whether emerg-
ing DS-1-like G1P[8] strains remain in circulation.
It was shown previously that mutations along the three main mapped neutralizing
epitopes of VP7 can generate vaccine escape mutants (50). For instance, amino acid
substitutions at positions 94, 97, 147, and 291 signiﬁcantly affect the antigenic recog-
nition of human G1 strains (50). When VP7 sequences of postvaccine G1P[8] strains (L3)
were compared to that of Rotarix, only the K291R (7-1a) substitution occurred within
the sites associated with antibody escape mutants, and this substitution was already
present among the strains circulating before vaccine introduction since 1998 and hence
was not selected due to potential vaccine pressure. Furthermore, both lysine (K) and
arginine (R) are positively charged polar proteins; hence, this substitution is unlikely to
produce signiﬁcant changes in the biochemical properties of VP7. The only substitution
present among the postvaccine G1 strains was N221S. As both asparagine (N) and
serine (S) are small noncharged residues, this substitution does not appear to have a
signiﬁcant impact on the overall conformation and structure of the protein surface.
However, the loss of an asparagine residue may have resulted in the loss of a potential
glycosylation site, which could affect VP7 antigenic determinants (51). This change does
not appear to be a universal glycosylation position, as serine also occurs naturally at
position 221 for some non-G1 strains like S2 (G2), RV-5 (G3), and ST5 (G4) strains (52).
While this change is outside the currently proven glycosylation sites (positions 69 to 71,
238 to 240, and 318 to 320), the N221S change occurred within neutralizing epitope C
(antigenic region C) of VP7 (52). In order to exclude the potential for this amino acid
substitution, further functional studies may be warranted, bearing in mind that changes
in immunogenicity and neutralization patterns have been attributed to different gly-
cosylation patterns using mutated laboratory strains (51, 53).
The only hydrophobic-to-hydrophilic change, which would potentially affect the
structural conformation and stability of proteins signiﬁcantly, occurred outside the
mapped antigenic regions at position 266 (alanine[A] to S) and was also present among
strains circulating pre-2009, those of L2. However, it is possible that substitutions in the
non-AR could affect the stability of the viral particle or protein assortment speciﬁcities,
since VP6 serves as an anchor for the outer capsid VP4 and VP7 proteins, where the 260
trimers of VP7 lie directly on top of the VP6 trimers (54). Contact with VP6 is facilitated
by the arm-like extensions formed by the VP7 N termini that also form a lattice with
other VP7 trimers. This interaction allows the gripping of VP7 to the intermediate VP6
layer and reinforces the integrity of the outer shell (55). Such interactions may drive the
selection of particular VP7 and/or VP4 lineages in reassortant strains and explain
lineage replacements that may not necessarily be explained exclusively in terms of
immune pressure. In a recent analysis, vaccine effectiveness against all G1P[8] strains 3
years after Rotarix introduction in Malawi was 82% (30), suggesting a high degree of
protection against atypical DS-1-like G1P[8] strains, given that these G1P[8] strains were
detected in randomly selected stool samples collected between 2013 and 2014. Further
analysis is under way in order to assess the extent of the spread of the DS-1-like G1P[8]
strains and to calculate vaccine effectiveness against various G and P types possessing
Wa- and DS-1-like genetic backbones.
In conclusion, genome reassortment and mutation are the major evolutionary
mechanisms that inﬂuenced the genetic diversity of G1P[8] strains that circulated in
Malawi from 1998 to 2014. Atypical DS-1-like G1P[8] strains emerged in 2013 through
genome reassortment events between Wa- and DS-1-like human strains that can be
traced back to the 1990s in Malawi. Mutations within outer capsid VP7 of Malawian
G1P[8] strains compared to RV1 had no impact on the structural conformation of
antigenic regions, suggesting little or no effect on the recognition of vaccine-induced
antibodies. Thus, the remaining genome segments (non-G or -P) might also play an
important role in immune evasion. It is likely that the atypical DS-1-like G1P[8] strains
emerged through natural strain evolutionary pressure, which is unrelated to vaccine
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use. However, the predominance of atypical reassortant DS-1-like G1P[8] strains, which
coincided with vaccine introduction, could suggest the positive selection of atypical
G1P[8] strains that were undergoing purifying selection. Vaccine effectiveness against
such atypical strains needs careful investigation.
MATERIALS AND METHODS
Rotavirus strains. Stool samples collected from children aged 5 years presenting with acute
gastroenteritis at QECH in Blantyre, Malawi, from 1998 to 2014 were utilized (27–29). Diarrhea case
deﬁnition, rotavirus screening, VP4 and VP7 genotyping, and descriptions of strains that circulated in
Malawi were reported previously (27–29). In total, 4,888 stool specimens were collected before vaccine
introduction (1997 to 2012), whereas 2,109 were collected after vaccine introduction (2013 to 2014).
Rotaviruses with G1P[8] outer capsid proteins were the only strains that were detected every year from
1998 to 2015 (comprising 554 strains isolated before and 95 strains isolated after vaccine introduction).
Therefore, only G1P[8] strains from each surveillance year, and from samples that had sufﬁcient fecal
material for dsRNA reextraction, were selected for further examination. Where available, a single fecal
sample from each month of each year was randomly selected for whole-genome sequencing; only
samples from which whole-genome data were obtained were included in the analysis. Ethical approval
was obtained from the National Health Sciences Research Committee, Lilongwe, Malawi (approval
number 867), and the Research Ethics Committee of the University of Liverpool, Liverpool, United
Kingdom (approval number 000490).
Preparation of puriﬁed dsRNA and cDNA for rotavirus whole-genome sequencing. Rotavirus
dsRNA was extracted and puriﬁed as previously described (17, 56). An additional DNase I treatment step
following a lithium chloride precipitation step was included to remove contaminating DNA (Sigma-
Aldrich, Dorset, UK). Puriﬁed dsRNA was quantiﬁed by using a Qubit 3.0 ﬂuorometer (Life Technologies,
CA, USA). Sequence-independent cDNA synthesis and PCR ampliﬁcation procedures described previously
(17, 56) were used to amplify cDNA for rotavirus whole genomes from samples with 2 ng/l dsRNA.
RNA and cDNA library construction and Illumina HiSeq sequencing. After denaturation of dsRNA
at 95°C for 5 min, ScriptSeq RNA-Seq Library Preparation kit V2 was used to generate Illumina sequencing
libraries for samples that had 2 ng/l dsRNA (Illumina Inc., CA, USA). Puriﬁed cDNA generated from
samples with2 ng/l dsRNA was subjected to standard bar-coding and library construction for Illumina
sequencing using a Nextera XT DNA library preparation kit (Illumina Inc., CA, USA). Rotavirus VP6-speciﬁc
quantitative PCR (qPCR) (57) and a 2100 bioanalyzer (Agilent Technologies Inc., CA, USA) were used to
perform quality control on the DNA libraries, followed by sequencing using the HiSeq 2000 platform
(Illumina Inc., CA, USA) at the Centre for Genomic Research (CGR), University of Liverpool, United
Kingdom.
Sequence assembly and determination of rotavirus genotypes. Illumina adapter sequences were
trimmed from the raw Fastq sequence data by using Cutadapt v1.2.1 (58) and Sickle v1.2 software (59).
Complete consensus nucleotide sequences were generated by mapping trimmed Illumina sequence
reads to various complete nucleotide sequences of prototype rotavirus genogroup strains by using both
de novo and reference DNA sequence assembler algorithms implemented in Geneious software v8 (60).
Rotavirus genotypes were assigned to each of the 11 genome segments by using the RotaC v2.0
Web-based automated rotavirus genotyping tool (http://rotac.regatools.be/) (7).
Sequence alignments and maximum likelihood phylogeny construction. Reference nucleotide
sequences for each rotavirus genome segment were retrieved from the rotavirus resource in the
GenBank database (61). This was followed by multiple-sequence alignment of the assembled sequences
for the study strains by using Muscle v3.8.31 (62), included in MEGA v6.0 (63). Initial phylogenetic trees
for each segment were inferred by using the maximum likelihood approach implemented in MEGA by
selecting the DNA model that best ﬁt the data according to the corrected Akaike information criterion
(AICc), as described previously (12). We used a generalized time-reversible (GTR) model with Gamma ()
heterogeneity across nucleotide sites, while the reliability of the branching order and partitioning were
assessed by performing 1,000 bootstrap replicates (64).
Bayesian inference of phylogenies and population dynamics. Coalescence analyses were per-
formed by using BEAUTi v1.7.5 and BEAST v1.8 (65, 66) with the following parameter speciﬁcations:
lognormal relaxed (uncorrelated) clock model (67), a constant-size coalescent tree prior, a Hasegawa-
Kishino-Yano (HKY85) nucleotide substitution model with estimated base frequencies (68), and a  site
heterogeneity model with 4 rate categories (69) and a prior mutation rate () of 1.0  103 nucleotide
substitutions/site/year, as previously reported by Zeller et al. (35). The maximum likelihood trees
generated as described above were used as starting trees for the Bayesian analysis in BEAST. We used
a GMRF tree prior, which also allows the investigation of the population dynamics, i.e., effective
population size (Ne) or relative genetic diversity, over time. A total of 200 million Markov chain Monte
Carlo (MCMC) iterations were performed and sampled every 40,000th generation. The ﬁrst 20 million
iterations (10% of the total) from the MCMC analysis, burn-in time, were discarded since these iterations
may represent states that the chain explored before reaching the equilibrium state of the target
distribution. The mean values and 95% HPDs of the mutation rates and the tMRCAs for each rotavirus
segment were calculated from the BEAST output by using Tracer v1.6.0 (https://tree.bio.ed.ac.uk/
software/tracer/). The MCC tree for each viral segment was generated by using Tree Annotator v2.1.2
(http://beast.bio.ed.ac.uk/treeannotator) and visualized by using FigTree v1.4.2 (http://tree.bio.ed.ac.uk/
software/ﬁgtree/) and BioPython scripts (70).
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Detection of natural selection in proteins encoded by rotavirus segments. ORFs that encode
both structural and nonstructural proteins were identiﬁed and extracted from the multiple-sequence
alignments of each rotavirus genomic segment. We used BioPython (70) scripts to extract and manip-
ulate the sequence alignments. The ORF alignments for each protein were then converted to the
corresponding codon alignments by using CodonAlign (http://www.hiv.lanl.gov/cgi-bin/CodonAlign).
The alignments were then used to calculate the global ratio of synonymous to nonsynonymous
substitutions (dN/dS) for each ORF by using single-likelihood ancestor counting (SLAC) (71) and a fast,
unconstrained Bayesian approximation for inferring selection (FUBAR) (72). To identify speciﬁc sites
under selection in the ORFs, we also used the mixed-effects model of episodic selection (MEME) (73),
random-effects likelihood (REL) (74), and ﬁxed-effects likelihood (FEL) (75) methods implemented in
DataMonkey, a Web server for the HyPhy package (76). The occurrence of genetic recombination was
checked by using GARD (31) and SBP (32). We used the following default signiﬁcance levels: P, Bayes
factor, or posterior probability values of 0.1 for SLAC, MEME, and FEL; 0.9 for FUBAR; and 50 for REL. The
HKY85 nucleotide substitution model, beta-gamma site-to-site rate variation, and neighbor-joining trees
were used for the selection analysis. All analyses were done by using the DataMonkey Web server (71).
Structure comparison between the outer capsid glycoprotein of RV1 and G1P[8] strains to
predict changes in antibody binding. To investigate the likely impact of amino acid substitutions on
anti-RV1 antibody recognition due to mutations that occurred over time within the antigenic regions of
Malawian G1P[8] rotaviruses, the structural conformations of the outer capsid glycoprotein of pre- and
postvaccine strains were compared to that of RV1. Representative VP7 sequences for each G1P[8] lineage
were utilized for protein structure modeling using Modeler version 9.17 (77). Templates were searched
in the Protein Data Bank (78), using an integrated Web-based HHpred program (79). The best model with
the highest zdope score was selected for analysis from the 100 models that were generated for each
sequence.
Accession number(s). All complete nucleotide and deduced amino acid sequences generated in this
study were deposited in GenBank (61) under accession numbers MG181227 to MG181941.
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